FCM
CL icon

Fieldview Capital Management’s Colgate-Palmolive CL Stock Holding History

Fieldview Capital Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-59,549
Closed -$4.76M – 508
2025
Q3 		$4.76M Buy
+59,549
New +$5.08M 0.78% 17
2025
Q2 		– Sell
-9,399
Closed -$881K – 371
2025
Q1 		$881K Buy
9,399
+2,071
+28% +$185K 0.12% 208
2024
Q4 		$666K Buy
+7,328
New +$699K 0.1% 249

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fieldview Capital Management's CL Position: Q4 2025 in Review

Fieldview Capital Management sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 59,549 shares — an estimated $4.76M sold.

Fieldview Capital Management first reported a position in CL in Q4 2024 and held it in 3 quarters. The position peaked at $4.76M in Q3 2025. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Fieldview Capital Management reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Fieldview Capital Management sold 59,549 Colgate-Palmolive shares in Q4 2025, an estimated $4.76M.
  • Fieldview Capital Management first reported a position in Colgate-Palmolive in Q4 2024 and held it in 3 quarters.
  • Fieldview Capital Management's Colgate-Palmolive position peaked at $4.76M in Q3 2025.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Fieldview Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.